Latest Calico News & Updates

See the latest news and media coverage for Calico. We track all announcements, press releases, and industry mentions in real time, all in one place.

Calico

Biotechnology company studying aging and developing potential therapies

calicolabs.com

Headquarters: South San Francisco, United States
Founded year: 2013
Company type: Private company
Number of employees: 490–500
Industry: Biotechnology & Medical Research

Last updated October 22

Latest news about Calico

In short: Calico received EMA PRIME designation for fosigotifator, its vanishing white matter treatment, after FDA Breakthrough Therapy status.

Company announcements

October 22 Calico

Calico receives EMA PRIME designation for VWM treatment fosigotifator

The designation follows US FDA Breakthrough Therapy status for the eIF2B activator targeting vanishing white matter, a rare disease with no approved therapies.

June 23 Calico

Calico announces FDA Breakthrough Therapy Designation for fosigotifator

The designation is for treating Vanishing White Matter disease, based on early clinical evidence.

November 5, 2025 Calico

Calico announces FDA orphan drug designation for ADPKD

The designation was granted for ABBV-CLS-628, an anti-PAPP-A antibody developed with AbbVie, which also has Fast Track status and is in Phase 2.

October 2, 2025 Calico

Calico announces FDA Fast Track Designation for ADPKD treatment

ABBV-CLS-628, an anti-PAPP-A monoclonal antibody developed with AbbVie, is in Phase 2 trials for ADPKD.

Media coverage

September 22 JAMA Network

DNL343 and Disease Progression in Amyotrophic Lateral Sclerosis

This randomized clinical trial evaluates the safety, tolerability, and efficacy of DNL343 for...

December 12, 2025 Nature

Calico, Alphabet's anti-ageing play, goes it alone

In 2013, Google launched Calico Life Sciences to develop drugs for the treatment of ageing and age-related diseases. It was an ambitious plan, prompting Time...

July 22, 2021 PharmaForum

AbbVie, Calico raise their age-related disease alliance funding to $3.5bn

AbbVie and Alphabet spin-out Calico Life Sciences have agreed to fund their seven-year-old partnership seeking treatments for diseases of ageing with another $500 million apiece...

June 26, 2018 STAT

Google's aging research spinout Calico gets another $1 billion commitment from Alphabet and AbbVie

AbbVie and Google parent company Alphabet are each committing $500 million to continue funding the scientists researching aging at the ambitious Alphabet unit called Calico...

Never miss news about Calico

Track Calico and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Calico competitors & trending companies

Browse news for competitors to Calico and other trending companies.